Loading...
XNAS
XXII
Market cap2mUSD
Dec 04, Last price  
1.05USD
1D
2.94%
1Q
-38.60%
Jan 2017
-93.58%
IPO
-94.62%
Name

22nd Century Group Inc

Chart & Performance

D1W1MN
XNAS:XXII chart
P/E
P/S
0.22
EPS
Div Yield, %
Shrs. gr., 5y
-22.53%
Rev. gr., 5y
-14.39%
Revenues
12m
-63.12%
000001,012,14118,7757,278,383528,9918,521,99812,279,97916,600,24426,426,34725,832,53028,111,00030,948,00062,111,00032,204,00011,878,000
Net income
-15m
L-89.23%
-59,786-29,672-82,146-55,469-89,933-1,353,903-6,735,281-26,153,158-15,595,358-11,031,931-11,581,430-13,029,117-7,966,911-24,195,578-19,711,000-32,609,000-59,801,000-140,775,000-15,164,000
CFO
-14m
L-73.91%
-43,186-33,547-42,451-87,591-32,004-3,449,430-1,764,4453,855,834-6,582,730-7,321,811-9,887,580-12,068,383-17,844,266-14,587,364-15,621,000-22,839,000-51,714,000-54,987,000-14,345,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
IPO date
Oct 17, 2006
Employees
198
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT